Objective: To identify the combined effect of prenatal and postnatal vitamin D3 supplementation on the vitamin D status of pregnant and lactating women and their exclusively breastfed infants.
T he circulating form of vitamin D (25-hydroxyvitamin D, or 25[OH]D) is considered the appropriate test to determine vitamin D status in vivo
. The Endocrine Society developed widely accepted parameters in which vitamin D deficiency is defined as a serum level of 25[OH]D less than 20 ng/ml, insufficiency is defined as 21 to 29 ng/ml, and sufficiency is defined as 30 ng/ml or greater . Exogenous factors such as sun exposure, latitude, skin pigmentation, and dietary sources of vitamin D affect circulating 25[OH]D levels. Controversies and lack of solid evidence persist regarding the ideal serum 25[OH]D level and the amount of vitamin D supplementation needed to achieve this level. Although most major medical societies and researchers have adopted the definitions of the Endocrine Society, the vitamin D supplementation amount needed to achieve specific serum levels remains unclear. Further, no consensus exists related to the optimal levels for circulating 25[OH]D across the lifespan, among men and women, or during pregnancy and lactation. Although severe disease does not present until 25[OH]D levels drop well into the deficient range, optimal health for humans across the lifespan appears to benefit from a 25 [OH] D level between 30 to 50 ng/ml Holick, 2011; Hosseinnezhad & Holick, 2013) .
The achievement of maternal vitamin D sufficiency during pregnancy and lactation has the potential to improve the health of women and
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infants simultaneously. Vitamin D is important in bone health and calcium homeostasis (Institute of Medicine, 2011) , but more recent evidence points to wider health implications of vitamin D deficiency. Specifically, vitamin D deficiency is associated with increased incidence and/or severity of metabolic disorders (Al-Daghri et al., 2013; Gorham et al., 2012; Kabadi, Lee, & Liu, 2012) , cardiovascular disease, and disordered immune response (Holick, 2004; Lucas, Ponsonby, Pasco, & Morley, 2008; Muscogiuri et al., 2012) . In pregnancy, vitamin D deficiency is associated with an increased risk of preeclampsia (Reeves et al., 2014; Robinson, Wagner, Hollis, Baatz, & Johnson, 2011; Robinson, Wagner, Hollis, Baatz, & Johnson, 2012; Smith, Kirkpatrick, Kovilam, & Agrawal, 2015) , altered immune response (Tamblyn, Hewison, Wagner, Bulmer, & Kilby, 2015; Vijayendra Chary et al., 2015) , and risk of preterm birth (Bodnar, Platt, & Simhan, 2015; Bodnar & Simhan, 2010) . Among infants, vitamin D deficiency is associated with lung dysfunction (Lykkedegn et al., 2015) , disordered immune response (Baek et al., 2014; Camargo et al., 2011; Chi et al., 2011; Jones et al., 2012; Jones et al., 2015; Tamblyn et al., 2015; Vijayendra Chary et al., 2015) , and suboptimal growth (Salama & El-Sakka, 2010; Teaema & Al Ansari, 2010) . Optimizing maternal vitamin D levels during pregnancy and lactation can directly benefit the woman, the developing fetus, and the growing infant.
Not only does vitamin D deficiency have a high prevalence, it also affects all age groups and has a demonstrated variability in incidence across population groups and individuals on the basis of ethnicity, geography/latitude, clothing/cultural practices, diet, and time spent outdoors (Looker et al., 2011; Marwaha et al., 2011; Schleicher, Sternberg, & Pfeiffer, 2013) . In the United States, vitamin D deficiency has been reported to affect as many as 42% of adults (Forrest & Stuhldreher, 2011) and 54% to 93% of pregnant women (Collins-Fulea, Klima, & Wegienka, 2012; Dror, King, Durand, & Allen, 2011; Ginde, Sullivan, Mansbach, & Camargo, 2010; Li et al., 2011) . Researchers suggest that infants with vitamin D-deficient mothers are also vitamin D deficient, and prevalence ranges from 28% to 90% (Basile, Taylor, Wagner, Quinones, & Hollis, 2007; Liang, Chantry, Styne, & Stephensen, 2010; Merewood et al., 2010; Merewood et al., 2012) .
Breast milk is the ideal food for human infants, but aberrations in maternal nutriture may negatively alter breast milk nutritional content and thus affect infant growth and development. Therefore, continued optimization of maternal nutritional status during breastfeeding is critical for the longterm health of the dyad. The American Academy of Pediatrics currently recommends infant supplementation with vitamin D3 at 400 IU/day starting at birth (Wagner, Greer, American Academy of Pediatrics Section on Breastfeeding, & American Academy of Pediatrics Committee on Nutrition, 2008 ). This recommendation is based on results from several studies that suggest that typically low amounts of vitamin D are transferred to infants via breast milk (Greer, Hollis, Cripps, & Tsang, 1984; Hollis, 1983; Hollis, Roos, Draper, & Lambert, 1981; Hollis, Roos, & Lambert, 1982; Taylor, Wagner, & Hollis, 2006; Wagner et al., 2008) . However, this recommendation has the potential to send mixed messages to women, who are told that their breast milk is ideal yet deficient. Increasing maternal vitamin D status to the sufficient range to promote vitamin D transfer to the infant via breast milk may eliminate the need to supplement exclusively breastfed infants with vitamin D3. In 2011, the Institute of Medicine increased the dietary reference intake for vitamin D from 400 IU to 600 IU daily for adults, including pregnant and lactating women (2011). Unfortunately, many of the prenatal vitamins in use today still contain 400 IU. Furthermore, some researchers argue that the dietary reference intake should be greater, for example, 800 to 4,000 IU (Garrett-Mayer, Wagner, Hollis, Kindy, & Gattoni-Celli, 2012; Mark et al., 2011) .
The primary purpose of this study was to examine the effect of maternal vitamin D3 supplementation on mean serum 25[OH]D in exclusively breastfed infants (see Figure 1) . Specifically, we examined the hypothesis that women who received adequate amounts of supplemental vitamin D3 starting in the third trimester of pregnancy would become replete by 4 to 6 weeks postpartum and thus provide sufficient vitamin D to their exclusively breastfed infants. Secondary hypotheses were that women in the intervention group would be vitamin D replete by childbirth and that their newborns would have significantly greater vitamin D serum levels than newborns in the control group.
Methods
A double-blind, randomized controlled trial was conducted to test our hypotheses. The study was conducted in a hospital-based obstetric practice between July 2012 and January 2013. The study was initiated after institutional review board approval. Women who presented for routine prenatal care between 24 and 28 weeks gestation were identified by the clinic nurse as potential study participants. Potential participants were approached by the research team members about participation in the study and were given a description of the study that included a review of inclusion and exclusion criteria. Inclusion criteria were pregnancy between 24 and 28 weeks, history of breastfeeding for at least 4 weeks with a prior infant, intent to breastfeed for at least 4 to 6 weeks, and maternal age 18 years or greater. Exclusion criteria were preexisting type 1 or type 2 diabetes, preexisting hypertension, parathyroid disease, uncontrolled thyroid disease, and use of vitamin D supplements beyond a prenatal vitamin in the last 6 months.
Eligible women who expressed interest in participation were asked to complete a written informed consent. They were then randomized to one of the two study groups on the basis of a concealed sequence that was developed before the actual randomization of participants. Women received two incentives for participation: a $10 gift card when they completed the blood draw at birth and a $30 gift card when they completed the blood draw at 4 to 6 weeks postpartum.
Intervention
A random sequence generator was used for group assignment corresponding to the participant numbers in a 1:1 ratio. This random sequence was generated independently from the research team. Participants were randomized to the placebo arm (prenatal vitamin containing 400 IU vitamin D3 plus a placebo capsule, both taken daily) or intervention arm (prenatal vitamin containing 400 IU vitamin D3 plus a vitamin D capsule containing 3,400 IU, both taken daily). Participants were instructed to take their assigned supplements daily starting on the day of enrollment through 4 to 6 weeks postpartum. The placebo capsule and the 3,400-IU vitamin D3 capsule were compounded using a vegetable cellulose base, were visually identical, and were packaged in identical pill bottles. The vitamin D3 and placebo were sealed in packets numbered to correspond with the coded random group assignment; this assignment was made by an unblinded member of the research team who was not involved in determining eligibility or recruiting participants. Blinding of the intervention was maintained at the level of participants, the data collector, and the data analyst until completion of all data collection. Thiele, D. K., Ralph, J., El-Masri, M., and Anderson, C. M.
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The daily vitamin D3 doses (control group ¼ 400 IU, intervention group ¼ 3,800 IU) were based on the current recommendation of 600 IU by the Institute of Medicine (IOM, 2011) and on the amount (4,000 IU) calculated by other researchers as required to meet physiologic needs during pregnancy, corresponding to vitamin D sufficiency (Hollis & Wagner, 2004a; Hollis & Wagner, 2004b; Wagner, Hulsey, Fanning, Ebeling, & Hollis, 2006; ) A research team member met with each participant every 30 days to assess intervention fidelity and to address any research-related questions or potential concerns they may have had. At the monthly meeting, participants returned any unused capsules and received a new 30-day supply of the study capsules. Participants were also contacted by phone or e-mail (their preference) at monthly intervals to correspond within 2 weeks of the face-to-face meeting. These bimonthly contacts allowed for further evaluation of intervention fidelity and maintained participant interest in the study.
A data safety monitoring board (DSMB) was created to monitor safety measures and conduct of the study. A serum 25[OH]D level greater than or equal to 90 ng/ml was set a priori as a trigger to notify the DSMB for review, although no data are available to suggest this would be a harmful level (Heaney, Davies, Chen, Holick, & Barger-Lux, 2003; Hollis, Johnson, Hulsey, Ebeling, & Wagner, 2011; Vieth, Chan, & MacFarlane, 2001) . When vitamin D analysis took place, results were reviewed by the one unblinded research team member with intent to report any abnormal values to the DSMB. Should this have occurred, the DSMB would have required that the participant exit the study, with follow-up serum analysis conducted to monitor for declining 25[OH]D levels. No study participants achieved 25[OH]D levels that met or exceeded this safety measure. Additional safety measures included analysis of serum calcium and parathyroid hormone levels on participant samples (women only) at childbirth and 4 to 6 weeks postpartum, because vitamin D promotes absorption of calcium in the gastrointestinal tract. Low parathyroid hormone and hypercalcemia represent markers of vitamin D toxicity. Calcium levels of 9.0 to 10.5 mg/dl and parathyroid levels of 10 to 55 pg/ml were used to define clinically appropriate levels.
Sample Size
Sample calculation for this study was based on the estimated effect size of the primary outcome of interest for this study: infant serum 25[OH]D levels at 4 to 6 weeks postpartum. On the basis of the effect size in studies by others implemented during the postpartum period (Hollis & Wagner, 2004b; Wagner et al., 2006) , it was determined that to detect a statistically significant difference in means of 8 ng/ml between the two infant groups, 14 participants equally divided between the two groups would be needed, for an alpha of 0.05 and assumed power of 80%. Thus, to offset loss to follow-up and attrition, a planned enrollment of 16 participants was established, with eight in each group.
Measures
At the time of enrollment to the study, maternal demographic characteristics were obtained, including self-identified race/ethnicity, age, and estimated due date. Participants' health records were accessed to gather prepregnancy weight, current weight, and calculated body mass index at enrollment, last menstrual period, estimated due date (calculated by obstetric care provider), gravidity, parity, and history of significant medical conditions. Additionally, at enrollment and at the final visit at 4 to 6 weeks postpartum, participants completed a Food Frequency Questionnaire that was patterned after the Harvard Service Food Frequency Questionnaire (Suitor, Gardner, & Willett, 1989) . Dietary intake data were collected to determine caloric and macro-and micronutrient dietary intake, including calcium and vitamin D. Baseline maternal health and pregnancy history data were obtained at enrollment into the study for each participant and repeated after birth to include labor and birth data and newborn anthropometric measurements through medical record abstraction.
After birth, each participant was instructed on the process to record the infant's daily intake of anything other than breast milk, namely formula (including brand and amount ingested) and direct vitamin D supplementation. Infant intake data were returned at 4 to 6 weeks postpartum for Nonfasting venous blood was collected from maternal participants at enrollment, birth, and 4 to 6 weeks postpartum and analyzed for serum 25 [OH]D, calcium, and parathyroid hormone. Nonfasting capillary blood via heel stick was collected from infant participants within 24 to 72 hours after birth and 4 to 6 weeks postpartum and analyzed for serum 25[OH]D levels. In pregnant women, blood samples at enrollment were collected by a laboratory technician, concurrent with regularly scheduled obstetric blood draws. Blood samples for both members of the dyad at the time of birth were collected concurrently with blood sampling for other obstetric and neonatal care needs. A research team member was present for blood collection and immediately transported samples to the laboratory for processing. At 4 to 6 weeks after birth, blood samples from the mother-infant dyad were collected and processed by a research team member. Blood samples were processed using established protocol with consistent equipment at a single location. Blood samples were centrifuged at 3,000 rpm for 10 minutes at 4 C. Serum was aliquoted (500 ml) and stored at -80 C until analysis. Maternal and infant samples were batch-analyzed for 25[OH]D at regular intervals to monitor for safety. The 25[OH]D was measured by enzyme immunoassay (Immunodiagnostic Systems Ltd., Gaithersburg, MD). Calcium levels were analyzed using the BioVision Calcium Colorimetric Assay. Parathyroid hormone was analyzed using the Abnova (Walnut, CA) parathyroid (human) enzyme-linked immunosorbent assay method. Clinical limits were used to define safe calcium levels of 9 to 10.5 mg/dl and parathyroid levels of 10 to 55 pg/ml.
Statistical Methods
The All data analyses were completed using a twotailed alpha of 0.05 as the criterion for statistical significance. Because season can be a major predictor of vitamin D status, it is important to note that all participants were recruited during summer months, gave birth in the fall, and completed the study by winter; this resulted in season as a uniform factor among all study participants and not a potential confounder in this study. Additionally, latitude can be a major predictor of vitamin D status, but all women were recruited from the same location (upper Midwestern United States, at 47 north latitude) and did not travel during the study time period.
Results
A total of 20 women were screened as potential participants. Two did not meet inclusion criteria, and two chose not to participate (see Figure 2) . A total of 16 women consented to join the study. At the time of consent, participants were allocated to Historically, vitamin D was thought to maintain calcium levels necessary for bone health, but researchers found broader implications such as the improvement of immune function.
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CNE their random assignment to one of two groups that resulted in an equal number of participants in the control and intervention groups (n ¼ 8/group). Among the control group participants, one left the study before initiation of the intervention, and one did not meet exclusion criteria because she consumed cod liver oil daily, which can contain high levels of vitamin D. Of the six remaining participants in the control group, all completed data collection at baseline and birth; however, three were lost to follow-up for the final 4-to 6-week postpartum visit. In the intervention group, one participant left the study before initiating the intervention. The remaining seven participants completed data collection at all time points.
Maternal characteristics at the time of enrollment into the study are presented in Table 1 . There were no significant differences between the two groups based on age, parity, gestation, body mass index, dietary vitamin D intake, or dietary calcium intake. All participants were White, so race was not analyzed. A statistically significant difference between groups was found in overall daily caloric intake, but this finding was not likely to affect vitamin D status. Table 2 ). The trend in decreasing 25[OH]D continued to the 4-to 6-week postpartum time point with further reduction in control group mean (21.9 AE 2.48 ng/ml) compared with the intervention group (35.98 AE 2.3 ng/ml; p ¼ .002; see Figure 3 ). None of the three control participants achieved sufficient Figure 4 ). All participants were successful in breastfeeding their infants, with only minor use of formula. The overall cumulative effect of the intervention for infants across the intervention approaches significance (p ¼ .065) and corresponds to a clinically significant difference between the two infant groups. No statistically significant relationship was found between maternal and infant vitamin D status after 4 to 6 weeks of exclusive breastfeeding, even though a difference was present at birth.
Discussion
In this study, women were randomly assigned to receive usual care (control group), which included ingestion of a prenatal vitamin each day and encouragement from their care providers to eat a well-rounded diet, or they received usual care plus an additional 3,400 IU of vitamin D3 daily, for a total of 3,800 IU vitamin D3 daily in the intervention group. Findings supported the hypothesis that if women were adequately supplemented during pregnancy and the postpartum period, they transferred adequate levels of vitamin D through their breast milk to their exclusively breastfed infants. Thiele, D. K., Ralph, J., El-Masri, M., and Anderson, C. M. . They were now able to include 15 studies in the review and conclude that vitamin D supplementation during pregnancy may reduce preeclampsia, preterm birth and low birth weight, but the evidence is mixed and does not necessarily support routine supplementation. Subsequent to the 2012 Cochrane review, two well-designed and executed randomized controlled trials were published (Hollis, Johnson, Hulsey, Ebeling, & Wagner, 2011; Wagner et al., 2013) . completed a three armed trial with 350 pregnant women that began at 12 to 16 weeks of pregnancy and continued through birth. Women received 400, 2,000, or 4,000 IU of vitamin D daily, and 25[OH]D (the biologically active form of vitamin D) and markers of vitamin D toxicity were analyzed. No adverse events related to the vitamin D supplementation were found, and women in the 4,000-IU group were significantly more likely to achieve vitamin D sufficiency (25[OH]D > 32 ng/ml), as were their infants at birth. Wagner et al. (2012) used a similar study design with two arms that included dosages of 2,000 IU or 4,000 IU daily. Pregnant women (n ¼ 257) were enrolled between 12 and 16 weeks and followed up through birth. No supplementation-related adverse events were reported, and both groups significantly increased their mean 25[OH]D serum levels with no significant difference between the two group means at birth. However, mean serum 25[OH]D levels in the infants born to women in the 4,000-IU group were significantly higher than in the infants born to women in the 2,000-IU group. Our findings were consistent with the findings from these two studies, which demonstrated a large effect size of maternal vitamin D supplementation during pregnancy on maternal and newborn vitamin D status. Our study had the added component of the continuation of the intervention for an additional 4 to 6 weeks after birth, which enabled us to analyze the effect on the exclusively breastfed infant and breastfeeding mother.
4-6 Weeks of Age
Researchers who specifically studied the transfer of vitamin D from mother to infant via exclusive breastfeeding were also minimally represented in the literature at the time of design of this study. In 2004 and Wagner et al. undertook small studies to determine the effect of vitamin D supplementation in breastfeeding women (initiated at 1 month postpartum) on their infants (Hollis & Wagner, 2004b; Wagner et al., 2006) . Authors of this early work showed that vitamin D was transferred from mother to infant through breast milk. Researchers conducted more complex studies with interventions initiated during early pregnancy and continued through the postpartum period (March et al., 2015) or initiated during established lactation (Hollis et al., 2015) and then followed, but these studies occurred well after the conceptualization and completion of our study. March et al. and Hollis et al. found significantly increased maternal and infant 25[OH]D serum levels when women received a maximum dose of 2,000 IU of vitamin D daily (March et al., 2015) or 6,400 IU of vitamin D daily (Hollis et al., 2015) . Additionally, infants who received placebo while their mothers received 6,400 IU of vitamin D daily during lactation had equivalent serum 25[OH]D compared to infants who received direct vitamin D supplementation. No researchers found an increased risk of hypercalcemia or hypercalciuria at these doses of vitamin D. March et al. used the same methodology that we did (i.e., vitamin D supplementation was initiated prenatally and continued through early postpartum). However, the dosage of vitamin D supplementation differed, and March et al.'s largest dose was 2,000 IU compared with our intervention of 3,600 IU, which leaves our findings unique in the field. With global rates of maternal vitamin D deficiency ranging from 17% to 62% during lactation, effective and safe methods to rectify maternal and infant vitamin D deficiency simultaneously are critical (Dawodu et al., 2015) .
The strength of this study is its unique design with initiation of vitamin D3 supplementation in pregnancy and continuation through the postpartum period. This design allowed for investigation of the separate effects of maternal supplementation during pregnancy and maternal supplementation during lactation on the vitamin D status of exclusively breastfed infants. Simultaneously, this design allowed for mothers and infants in the intervention group to have the greatest opportunity to reach sufficient vitamin D status before birth. Interestingly, researchers found that the parent compound vitamin D (the form manufactured in the skin) and not the Thiele, D. K., Ralph, J., El-Masri, M., and Anderson, C. M.
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CNE circulating form (25[OH]D) that has been metabolized by liver enzymes, is the form that passes from mother to infant via breast milk (Wagner, Taylor, Johnson, & Hollis, 2012) . This finding is important because the parent vitamin D has a half-life of 12 to 24 hours; thus, the breastfeeding mother must take a daily vitamin D supplement to pass adequate levels to her infant, rather than larger doses at greater intervals, which may increase her 25[OH]D level but will not benefit her infant as much (Hollis et al., 2015; Wagner et al., 2012 ). It appears that vitamin D status, as assessed through cord blood 25[OH]D levels, may have the greatest effect on programming the developing immune system (Chi et al., 2011; Jones et al., 2015; Vijayendra Chary et al., 2015) . For the long-term health of offspring, optimum vitamin D levels should be achieved during fetal development and into early childhood, particularly through exclusive breastfeeding. The American Academy of Pediatrics continues to recommend vitamin D supplementation for all exclusively breastfed infants. This recommendation is supported by the literature and the high prevalence of vitamin D deficiency in lactating women (Wagner et al., 2008) . However, if a health care provider encounters a woman who is particularly keen to avoid all non-breast milk supplements, she could be counseled that vitamin D adequacy can be achieved through her own adequate supplementation. Women will need to be diligent about their daily supplementation to maximize the health benefits for themselves and their infants. This study was limited by small sample size and lack of generalizability to more racially diverse populations of women. The ability to recognize statistically significant differences between such small groups speaks to the large effect size of vitamin D3 supplementation and the ease of transforming vitamin D status is a relatively short amount of time. In this study, 38% of the participants (all White race) were vitamin D deficient when they enrolled in the study, which occurred at the end of the summer season. This time of year represents peak vitamin D status and confirms the high rate of vitamin D deficiency seen in pregnant women but particularly highlights the vulnerability of women of U.S. racial and ethnic minority groups who are at increased risk for vitamin D deficiency (Bodnar et al., 2007; CollinsFulea et al., 2012; Dawodu et al., 2013; Dror et al., 2011; Li et al., 2011; Merewood et al., 2010) .
Conclusion
It was historically understood that human breast milk was so low in vitamin D that direct supplementation of breastfed infants was required (Kunz, Niesen, von Lilienfeld-Toal, & Burmeister, 1984; Wagner et al., 2008) . Early work on the vitamin D content of human milk challenged this perception and sparked further investigation (Ala-Houhala, 1985; Ala-Houhala, Koskinen, Parviainen, & Visakorpi, 1988; Greer, Hollis, Cripps, et al., 1984; Greer, Hollis, & Napoli, 1984; Hollis et al., 1981; Hollis, Pittard, & Reinhardt, 1986; Specker, Tsang, & Hollis, 1985) . To frame this line of research from an evolutionary point of view, it is not biologically plausible that human milk would be uniformly deficient in a nutrient so critical to human development. Vitamin D deficiency is often discussed by women who exclusively breastfeed their infants and choose to decline infant vitamin supplementation. As we consider that our ancestors evolved to receive varying amounts of sunlight in accordance with skin pigmentation, latitude, and dietary intake factors, we are currently faced with a pandemic of vitamin D deficiency related to modern lifestyle factors. These factors include spending most daylight hours indoors, use of sunscreens, and migration to northern latitudes. On the basis of these factors, and much larger studies recently published (Hollis et al., 2015; March et al., 2015) , clinicians can be assured that maternal supplementation with oral vitamin D3 at adequate doses can positively affect maternal vitamin D status, vitamin D status of newborns, and the vitamin D status of exclusively breastfed infants. Our findings support that direct infant vitamin supplementation can be eliminated when maternal vitamin D sufficiency is achieved. Clinicians should consider human milk as the best source of infant nutrition, and deficiencies in human milk indicate maternal nutritional aberrations, which should be corrected to improve the health of the mother and infant.
When properly supplemented, women are able to pass adequate vitamin D to their exclusively breastfed infants, which improves the health of both simultaneously.
